Key Takeaways
- • Lissun, a health-tech startup focused on children with special needs and developmental delays, closed a Series A funding round of INR 48 crores led by Colossa Ventures.
- • The round included participation from Physis Capital as a new investor, alongside existing backers RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures, and SucSEED Ventures, plus new partners New Age India Fund and Beyond Capital Ventures.
- • Capital will be deployed to expand the Sunshine by LISSUN network of child development centers across key Indian cities, develop proprietary AI-led solutions, and strengthen clinical processes across the platform.
- • Lissun operates a dual-model strategy combining physical child development centers with AI-enabled platforms designed to reach populations lacking access to quality developmental care, with significant scaling potential across India's underserved markets.
- • The funding reflects investor confidence in the single-specialty health-tech model and positions Lissun to move beyond center-based service delivery toward scalable, technology-driven interventions.
Summary
Lissun, a single-specialty health-tech platform serving children with special needs and developmental delays, announced the successful closure of its Series A funding round worth INR 48 crores on August 18, 2026. The round was led by Colossa Ventures, with participation from newly entered investor Physis Capital and a broad coalition of existing shareholders including RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures, and SucSEED Ventures. New partners New Age India Fund and Beyond Capital Ventures also participated, expanding the company's investor base.
The company operates through Sunshine by LISSUN, a branded network of child development centers scaled across India, alongside a suite of AI-powered platforms and diagnostic tools built on proprietary technology and clinical data. Krishna Veer Singh, Co-founder and CEO, emphasized the strategic importance of technology to Lissun's expansion: "Our AI tools largely support therapists and parents — but the bigger opportunity is building AI-led solutions on our own proprietary technology and data, with the potential to reach millions of children across India who lack access to quality developmental care."
The fresh capital will be allocated across three primary initiatives: expanding the Sunshine by LISSUN center network into key metropolitan areas, developing proprietary AI-led solutions leveraging the company's accumulated data and clinical expertise, and strengthening clinical processes across the existing network. Tarun Gupta, Co-founder of Sunshine by LISSUN, outlined the vision as building an ecosystem where technology, therapists, and human support converge. The next phase aims to scale this specialty model beyond center-based delivery toward proprietary AI products with significantly greater reach across India's underserved populations.
This funding milestone positions Lissun at an inflection point where capital can be directed toward both organic expansion of physical centers and development of scalable technology solutions. The investment signals market confidence in the single-specialty health-tech model and the addressable opportunity in pediatric developmental care across India, where access to specialized services remains constrained.
The company operates through Sunshine by LISSUN, a branded network of child development centers scaled across India, alongside a suite of AI-powered platforms and diagnostic tools built on proprietary technology and clinical data. Krishna Veer Singh, Co-founder and CEO, emphasized the strategic importance of technology to Lissun's expansion: "Our AI tools largely support therapists and parents — but the bigger opportunity is building AI-led solutions on our own proprietary technology and data, with the potential to reach millions of children across India who lack access to quality developmental care."
The fresh capital will be allocated across three primary initiatives: expanding the Sunshine by LISSUN center network into key metropolitan areas, developing proprietary AI-led solutions leveraging the company's accumulated data and clinical expertise, and strengthening clinical processes across the existing network. Tarun Gupta, Co-founder of Sunshine by LISSUN, outlined the vision as building an ecosystem where technology, therapists, and human support converge. The next phase aims to scale this specialty model beyond center-based delivery toward proprietary AI products with significantly greater reach across India's underserved populations.
This funding milestone positions Lissun at an inflection point where capital can be directed toward both organic expansion of physical centers and development of scalable technology solutions. The investment signals market confidence in the single-specialty health-tech model and the addressable opportunity in pediatric developmental care across India, where access to specialized services remains constrained.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.